Shah Rukh Khan’s King poster draws AI-generated criticism
Shah Rukh Khan’s new poster for the film King faces online backlash over alleged AI use and visual similarities to Ranveer Singh’s upcoming project.

Shah Rukh Khan unveiled a promotional poster for his upcoming action film King on Tuesday, sparking online debate over the image's production. The film is scheduled for a December 24 release.
While fans noted the 60-year-old actor's rugged aesthetic, critics alleged the poster was generated using artificial intelligence. Online users drew comparisons between the image's composition and marketing materials for Ranveer Singh’s spy film, Dhurandhar: The Revenge, citing similarities in lighting and framing.
King reunites Khan with director Siddharth Anand and King reunites Khan with director Siddharth Anand and features his first on-screen collaboration with his daughter, Suhana. The poster includes a tagline referencing Khan's 1990 film Badshaah, which supporters interpreted as a nod to his cinematic legacy.
Despite the aesthetic debate, the film remains a high-profile project for the Indian box office. The production team has not addressed the claims regarding the poster's creation process.
More stories
- TCM faces uncertainty under Paramount Skydance's $80bn debt
- California court upholds Danny Masterson's 30-year rape sentence
- Sam Fender seeks cuts to 2027 tour ticket prices
- Macklemore repeats Palestine call in 17-song Red Rocks set
- Ronson and Remi gather 11 acts for Amy Winehouse tribute
- Jason Molina documentary revisits his nearly 20-album legacy
Latest news
- Kinross Gold faces Q3 test after 2%-3% output cut
- Ruto seeks Russian investment in Kenya's $380m trade push
- Sudan teachers seek 20% budget share with 8m children outside school
- Spain rail network faces scrutiny after 64 killed near Toledo
- Private equity firms face scrutiny over third of methadone clinics
- Spain reports at least 30 dead in high-speed train crash
- Villa Vie disembarks 203 passengers in Cambodia over fuel costs
- Private equity puts $18.4bn into US healthtech deals

